Gad: Clinical Trials

1 trial of Gad, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Gad: new trials by email Literature Review of Gad trials Research Report on Gad

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
rhGAD65, Placebo - Type 1 Diabetes Mellitus
Phase 3TerminatedDiamyd Therapeutics AB3342008-07-012011-10-10

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)

Sponsors

Diamyd Therapeutics AB (1)

Countries

Finland (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Slovenia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Johnny Ludvigsson, MD, PhD (1)

Results publications

PMID 22296077, PMID 24302596, PMID 28357504